KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Biolife Solutions (BLFS) Short-Term Debt issuances (2016 - 2021)

Biolife Solutions (BLFS) reported Short-Term Debt issuances of $856000.0 for Q4 2021, down 94.16% on a QoQ basis from $14.6 million in Q3 2021.

Biolife Solutions (BLFS) has 2 years of Short-Term Debt issuances data on file, last reported at $856000.0 in Q4 2021.

  • Quarterly Short-Term Debt issuances changed N/A year-over-year to $856000.0 in Q4 2021, while the trailing twelve-month figure through Dec 2022 was $15.5 million (changed 0.0% YoY) and the FY2021 annual result came in at $27.3 million, changed N/A from the prior year.
  • Short-Term Debt issuances declined to $856000.0 in Q4 2021 per BLFS's latest filing, from $14.6 million in the prior quarter.
  • Across five years, Short-Term Debt issuances topped out at $14.6 million in Q3 2021 and bottomed at $856000.0 in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Short-Term Debt issuances (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn -
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn 11.00 Mn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn -
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn -
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn -
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 22.00 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn -
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn -
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 7.00 Mn
10 Biolife Solutions 1.20 Bn 1.12 Bn 17.50 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2021 856,000.00
Dec 31, 2021 856,000.00
Sep 30, 2021 14.65 Mn
Sep 30, 2021 14.65 Mn
Dec 31, 2016 1.00 Mn
Dec 31, 2016 1.00 Mn
Sep 30, 2016 1.00 Mn
Sep 30, 2016 1.00 Mn